| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.2505 | 52 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.9365 | 45 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.0943 | 28 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.2506 | 19 |
| GSM780720 | Untreated after 4 days (C2_2) | 53.9972 | 58 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.1594 | 10 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.0888 | 32 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.2275 | 38 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 50.0192 | 49 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.8871 | 36 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.5144 | 47 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.9836 | 41 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.8654 | 59 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.764 | 36 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.7016 | 57 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.4177 | 47 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.6004 | 44 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.631 | 30 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 38.9084 | 4 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.7348 | 40 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.7025 | 44 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.6984 | 47 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.2846 | 42 |